Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

7.50
Delayed Data
As of 3:59pm ET
 -1.36 / -15.35%
Today’s Change
5.25
Today|||52-Week Range
78.05
-39.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line-17.6M-10.5M-6.5M-3.4M
 
 
 
 
 
Depreciation166.0K159.0K46.0K96.0K
 
 
 
 
 
Total Other Cash Flow1.2M579.0K448.0K454.0K
 
 
 
 
 
Funds From Operations-16.3M-9.8M-6.0M-2.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-692.0K9.5M6.2M4.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-15.6M-19.3M-12.2M-7.1M
 
 
 
 
 
 
InvestingIncrease In Investments-13.6M-24.7M-9.2M-32.2M
 
 
 
 
 
Decrease In Investments37.2M35.8M31.6M9.2M
 
 
 
 
 
Capital Expenditures-13.0K-18.0K0.000.00
 
 
 
Fixed Asset Disposal----0.00266.0K
 
 
Net Cash Flow Investing23.6M11.1M22.4M-22.7M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction-2.3M-2.3M-2.3M-2.3M
 
 
 
 
 
Net Proceeds Stock Sale7.8M1.0K0.000.00
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing5.5M-2.3M-2.3M-2.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash13.5M-10.6M7.8M-32.1M